共 71 条
[1]
Diamantidis CJ(2018)Simultaneous risk factor control using telehealth to slow progression of diabetic kidney disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial Contemporary Clinical Trials 69 28-39
[2]
Bosworth HB(2018)Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies Metabolomics 14 128-77
[3]
Oakes MM(2017)Metabolomics and gene expression analysis reveal down-regulation of the citric acid (TCA) cycle in non-diabetic CKD patients eBioMedicine 26 68-22351
[4]
Do KT(2006)Compensatory responses to pyruvate carboxylase suppression in islet beta-cells: PRESERVATION OF GLUCOSE-STIMULATED INSULIN SECRETION* Journal of Biological Chemistry 281 22342-972
[5]
Wahl S(2017)Effect of empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease Circulation 136 969-10048
[6]
Raffler J(2009)FiehnLib: Mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry Analytical Chemistry 81 10038-717
[7]
Hallan S(2002)Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: A comprehensive table Clinical Chemistry. 48 708-520
[8]
Afkarian M(2020)Metabolomic markers of kidney function decline in patients with diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study American Journal of Kidney Diseases 76 511-4364
[9]
Zelnick LR(2018)Urine tricarboxylic acid cycle metabolites predict progressive chronic kidney disease in type 2 diabetes Journal of Clinical Endocrinology and Metabolism 103 4357-419
[10]
Jensen MV(1985)Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-1166